Creative Diagnostics is an American biotechnology company that specializes in the research and manufacturing of antibodies, viral antigens, diagnostic components, and critical assay reagents.[1][2]
Founding
Creative Diagnostics was founded in Shirley, New York, USA in 2005. Originally, the business was focused on monoclonal and polyclonal antibodies.[3][4] Later, various kinds of antibodies, viral antigens, reagents, medical kits, and biological services were launched to broaden the company's activities.[2]
Partnerships
Since 2010, Creative Diagnostics has maintained a commercial partnership agreement with CD Genomics, Inc. The two companies also began a platform license agreement in 2012.
Operations
Creative Diagnostics provides contract research and manufacturing services. Additionally, the company conducts ELISA testing.[5] Other products include:
- Matched antibody pairs
- Anti-idiotypic Antibodies
- HBV Core Antigen
- Antibody Isotyping Kits
- Protein Antigen Expression Service
- Fluorescent Dye Labeling
- DNA Immunization Antibody Production
References
- ^ Miller, Silke; Rao, Sara; Wang, Weiya; Liu, Hantao; Wang, Judy; Gavva, Narender R (2014). "Antibodies to the Extracellular Pore Loop of TRPM8 Act as Antagonists of Channel Activation". PLOS ONE. 9 (9): e107151. Bibcode:2014PLoSO...9j7151M. doi:10.1371/journal.pone.0107151. PMC 4159296. PMID 25203266.
- ^ a b Kurdi, Mohiadeen; Abughararah, Muath; Mulike, Mohammed; Yamani, Omar; Bugdady, Mohammed; Noor, Mamdooh (June 2014). "Molecular detection of hepatitis B virus (HBV) among voluntary ELISA positive blood donors in Almadinah Almunawwarah". Journal of Taibah University Medical Sciences. 9 (2): 166. doi:10.1016/j.jtumed.2014.01.002.
- ^ "The Way We Take Care of Antibody Purification". APSence. Retrieved December 16, 2014.
- ^ "Creative Diagnostics unveils custom antibody production service". Jun 11, 2015. Retrieved Jun 11, 2015.
- ^ "Human Bone Marrow Stromal Cell Antigen 1, BST1 ELISA Kit" (PDF). funakoshi. Archived from the original (PDF) on 2015-07-10. Retrieved 2015-07-09.